| Description |
| Product Type |
Product Size |
| Syrup |
1'S |
| Product Company |
| Sanofi |
Promethazine 120ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Topotecan 4mg/4ml
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Carboplatin 150mg/15ml |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| GSK |
Ceitrizine 10mg
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Macter Pharma
|
Zoledronic Acid 4mg/5ml
|
| Content | Promethazine is used to prevent and treat nausea and vomiting related to certain conditions (such as before/after surgery, motion sickness). It is also used to treat allergy symptoms such as rash, itching, and runny nose. It may be used to help you feel sleepy/relaxed before and after surgery or to help certain opioid pain relievers (such as meperidine) work better.
| Topotecan is an antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer.
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching.
| Zoledronic acid is used to treat high levels of calcium in the blood that may be caused by certain types of cancer.
|
Reviews
There are no reviews yet.